A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans
- 1 July 1999
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 73 (7) , 5903-5911
Abstract
During 1997 in Hong Kong, 18 human cases of respiratory illness, including 6 fatalities, were caused by highly pathogenic avian influenza A (H5N1) viruses. Since H5 viruses had previously been isolated only from avian species, the outbreak raised questions about the ability of these viruses to cause severe disease and death in humans. To better understand the pathogenesis and immunity to these viruses, we have used the BALB/c mouse model. Four H5N1 viruses replicated equally well in the lungs of mice without prior adaptation but differed in lethality for mice. H5N1 viruses that were highly lethal for mice were detected in multiple organs, including the brain. This is the first demonstration of an influenza A virus that replicates systemically in a mammalian species and is neurotropic without prior adaptation. The mouse model was also used to evaluate a strategy of vaccination against the highly pathogenic avian H5N1 viruses, using an inactivated vaccine prepared from nonpathogenic A/Duck/Singapore-Q/F119-3/97 (H5N3) virus that was antigenically related to the human H5N1 viruses. Mice administered vaccine intramuscularly, with or without alum, were completely protected from lethal challenge with H5N1 virus. Protection from infection was also observed in 70% of animals administered vaccine alone and 100% of mice administered vaccine with alum. The protective effect of vaccination correlated with the level of virus-specific serum antibody. These results suggests a strategy of vaccine preparedness for rapid intervention in future influenza pandemics that uses antigenically related nonpathogenic viruses as vaccine candidates.Keywords
This publication has 26 references indexed in Scilit:
- Characterization of the Surface Proteins of Influenza A (H5N1) Viruses Isolated from Humans in 1997–1998Virology, 1999
- Characterization of Avian H5N1 Influenza Viruses from Poultry in Hong KongVirology, 1998
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virusThe Lancet, 1998
- Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory IllnessScience, 1998
- Adjuvant Activity of the Heat-Labile Enterotoxin from Enterotoxigenic Escherichia coli for Oral Administration of Inactivated Influenza Virus VaccineThe Journal of Infectious Diseases, 1997
- Recombinant neuraminidase vaccine protects against lethal influenzaVaccine, 1996
- Influenza A Virus Vaccines Containing Purified Recombinant H3 Hemagglutinin Are Well Tolerated and Induce Protective Immune Responses in Healthy AdultsThe Journal of Infectious Diseases, 1995
- Genetic Stability of A/Ann Arbor/6/60 Cold-Mutant (Temperature-Sensitive) Live Influenza Virus Genes: Analysis by Oligonucleotide Mapping of Recombinant Vaccine Strains Before and After Replication in VolunteersThe Journal of Infectious Diseases, 1984
- Induction of Partial Immunity to Influenza by a Neuraminidase-specific VaccineThe Journal of Infectious Diseases, 1974